{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:09:29Z","timestamp":1781136569482,"version":"3.54.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00162","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T14:06:07Z","timestamp":1553609167000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Association Between Medication Adherence and Oxidative Stress in Patients With First-Episode Mania"],"prefix":"10.3389","volume":"10","author":[{"given":"Sa\u00ednza","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Alberich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina S.","family":"MacDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Mart\u00ednez-Cengotitabengoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificaci\u00f3n","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Zorrilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Leza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jad.2012.05.041","article-title":"Psychiatrists' perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries","volume":"143","author":"Vieta","year":"2012","journal-title":"J Affect Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review","volume":"36","author":"Garc\u00eda","year":"2016","journal-title":"J Clin Psychopharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12888-016-1159-0","article-title":"Online psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled trial","volume":"16","author":"Gonz\u00e1lez-Ortega","year":"2016","journal-title":"BMC Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.4088\/JCP.08m04221","article-title":"Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response","volume":"70","author":"Lindenmayer","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1034\/j.1600-0447.2002.1r084.x","article-title":"Treatment non-adherence in affective disorders","volume":"105","author":"Lingam","year":"2002","journal-title":"Acta Psychiatr Scand."},{"key":"B6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40345-016-0063-3","article-title":"Psychometric properties and validation of a four-item version of the Strauss\u2013Carpenter scale in bipolar disorder","volume":"4","author":"Alberich","year":"2016","journal-title":"Int J Bipolar Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12916-015-0529-7","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies","volume":"13","author":"Fernandes","year":"2015","journal-title":"BMC Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/schbul\/sbv078","article-title":"BDNF and NGF signalling in early phases of psychosis: relationship with inflammation and response to antipsychotics after 1 year","volume":"42","author":"Martinez-Cengotitabengoa","year":"2016","journal-title":"Schizophr Bull."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0891-5849(00)00394-4","article-title":"Total antioxidant capacity as a tool to assess redox status: critical view and experimental data","volume":"29","author":"Ghiselli","year":"2000","journal-title":"Free Radic Biol Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1440-1819.2006.01532.x","article-title":"Total antioxidant response in patients with schizophrenia","volume":"60","author":"Ustundag","year":"2006","journal-title":"Psychiatry Clin Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-244X-11-26","article-title":"Reduced antioxidant defense in early onset first-episode psychosis: a case-control study","volume":"11","author":"Mic\u00f3","year":"2011","journal-title":"BMC Psychiatry."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0194685","DOI":"10.1371\/journal.pone.0194685","article-title":"The complex association between the antioxidant defense system and clinical status in early psychosis","volume":"13","author":"Garc\u00eda","year":"2018","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(16)00143-4","article-title":"Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study","volume":"387","author":"Hou","year":"2016","journal-title":"Lancet Lond Engl."},{"key":"B15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/1871527315666160321104059","article-title":"Mood stabilizers, oxidative stress and antioxidative defense in euthymia of bipolar disorder","volume":"15","author":"Bengesser","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet Lond. Engl."},{"key":"B17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jpsychires.2015.07.003","article-title":"Oxidative stress in drug na\u00efve first episode psychosis and antioxidant effects of risperidone","volume":"68","author":"Noto","year":"2015","journal-title":"J Psychiatr Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s13311-016-0438-2","article-title":"The atypical antipsychotic paliperidone regulates endogenous antioxidant\/anti-inflammatory pathways in rat models of acute and chronic restraint stress","volume":"13","author":"MacDowell","year":"2016","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.12.025","article-title":"Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia","volume":"116","author":"MacDowell","year":"2017","journal-title":"Neuropharmacology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1399-5618.2006.00368.x","article-title":"Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment","volume":"8","author":"Gonzalez-Pinto","year":"2006","journal-title":"Bipolar Disord."},{"key":"B21","volume-title":"Entrevista Cl\u00ednica Estructurada Para los Trastornos del eje-I del DSM-IV","author":"First","year":"1999"},{"key":"B22","first-page":"171","article-title":"[Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients]","volume":"22","author":"Peralta","year":"1994","journal-title":"Actas Luso Esp Neurol Psiquiatr Cienc Afines."},{"key":"B23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry J Ment Sci."},{"key":"B25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"B26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","article-title":"A children's global assessment scale (CGAS)","volume":"40","author":"Shaffer","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"B27","volume-title":"Early Clinical Drug Evaluation Unit (ECDEU) Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"B28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jval.2016.07.001","article-title":"Psychometric properties of the four-item morisky green levine medication adherence scale among atherosclerosis risk in communities study (ARIC) Participants","volume":"19","author":"Beyhaghi","year":"2016","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res."},{"key":"B30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal Biochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/schbul\/sbt001","article-title":"Pro-\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia","volume":"40","author":"Garc\u00eda-Bueno","year":"2014","journal-title":"Schizophr Bull."},{"key":"B32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mce.2014.12.013","article-title":"The Keap1-NRF2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome","volume":"401","author":"Vriend","year":"2015","journal-title":"Mol Cell Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jchromb.2016.02.002","article-title":"The functional interactome of GSTP: a regulatory biomolecular network at the interface with the NRF2 adaption response to oxidative stress","volume":"1019","author":"Bartolini","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s12035-016-9707-7","article-title":"NRF2 weaves an elaborate network of neuroprotection against stroke","volume":"54","author":"Jiang","year":"2016","journal-title":"Mol Neurobiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4088\/JCP.09r05268yel","article-title":"Antipsychotic medication and oxidative cell stress: a systematic review","volume":"72","author":"Lepping","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/neu.2015.47","article-title":"Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture","volume":"28","author":"Gawlik-Kotelnicka","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.biopha.2017.09.027","article-title":"Lithium induced oxidative damage and inflammation in the rat's heart: protective effect of grape seed and skin extract","volume":"95","author":"Mezni","year":"2017","journal-title":"Biomed Pharmacother Biomedecine Pharmacother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.tiv.2017.07.008","article-title":"The role of oxidative stress in antipsychotics induced ovarian toxicity","volume":"44","author":"Elmorsy","year":"2017","journal-title":"Toxicol. Vitro Int. J. Publ. Assoc. BIBRA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.psychres.2012.07.024","article-title":"Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: a 12-months follow-up study","volume":"200","author":"Ruiz-Litago","year":"2012","journal-title":"Psychiatry Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/pcn.12333","article-title":"First-episode psychosis is associated with oxidative stress: effects of short-term antipsychotic treatment","volume":"69","author":"Sarandol","year":"2015","journal-title":"Psychiatry Clin Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4088\/JCP.7090su1cj.x","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00162\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T08:48:56Z","timestamp":1553849336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00162\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":42,"alternative-id":["10.3389\/fpsyt.2019.00162"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00162","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"article-number":"162"}}